We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

ZEUS SCIENTIFIC

ZEUS Scientific provides high-performing, easy-to-use clinical diagnostic solutions. The company’s products are desig... read more Featured Products: More products

Download Mobile App




State-of-the-Art IFA Automation Solution Improves Laboratory Workflow

By LabMedica International staff writers
Posted on 19 May 2023
Print article
Image: The ZEUS dIFine digital immunofluorescence system (Photo courtesy of ZEUS Scientific)
Image: The ZEUS dIFine digital immunofluorescence system (Photo courtesy of ZEUS Scientific)

Laboratories are focused on improving efficiency, accuracy, and most importantly, productivity. Now, a complete system for indirect fluorescent antibody (IFA) slide processing and digital immunofluorescence imaging allows labs to increase their productivity while leaving them free to focus on more important tasks.

ZEUS Scientific’s (Branchburg, NJ, USA) new dIFine 30 System combines its next-generation digital IFA imaging and interpretation system with its user-friendly and efficient benchtop instrument for IFA slide processing, including cover slipping. The SP30, a fully automated IFA slide processor for the dIFine digital immunofluorescence system, is an easy-to-use and efficient walk-away benchtop instrument. Capable of processing up to 240 samples on 30 IFA slides, including cover slipping, the SP30 IFA slide processor for dIFine is engineered to enhance laboratory workflow and guarantee superior results.

ZEUS dIFine represents the future of IFA imaging and pattern recognition. This FDA-approved, automated digital scanner equipped with intelligent software is designed to acquire, analyze, display, and store digital images of ZEUS HEp-2 IFA slides. ZEUS dIFine rapidly generates positive/negative results and has received FDA clearance to suggest eight common ANA HEp-2 patterns (homogenous, speckled, centromere, nucleolar, nuclear dots, nuclear membrane, cytoplasmic, ribosomal, and mitochondrial). Additionally, dIFine can quickly locate and identify mitotic cells to aid in pattern identification. The ability to rapidly view and validate all negative samples with a single mouse click saves the user precious time. The built-in pattern atlas serves as a reference and a useful training tool, allowing for side-by-side comparison of images with ZEUS proprietary images aligned with ICAP nomenclature.

Related Links:
ZEUS Scientific 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Dengue Virus Test
LINEAR Dengue-CHIK

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.